SHENYANG, China, May 11 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release unaudited financial results for the first quarter ended March 31, 2010 on May 16, 2010 at 8:00pm (Eastern).
Following the earnings announcement, 3SBio's senior management will host a conference call at 5:00 am (Pacific) / 8:00 am (Eastern) / 8:00 pm (Beijing/Hong Kong) on May 17, 2010 to discuss its 2010 first quarter financial results and recent business activity.
The conference call may be accessed using the dial-in numbers below: Conference ID: 74760426 Local dial-in: China - landline 800 819 0121 China - mobile 400 620 8038 Hong Kong - 852 2475 0994 International toll-free dial-in: Hong Kong 800 930 346 United Kingdom 080 8234 6646 United States 1 866 519 4004 International toll dial-in: 65 6723 9381
A telephone replay will be available two hours after the call until May 24, 2010 at:
International dial-in: +61-2-8235-5000 United States dial-in: 1-866-214-5335 Replay- Conference ID: 74760426
A live webcast of the conference will be available on the investor relations page of 3SBio's website at http://bbs.3sbio.com/en/News/xinvestors.aspx and at http://tinyurl.com/3sbio2010Q1 . A replay of the webcast will be available within one hour after the conclusion of the call.
About 3SBio Inc.
3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China. For more information, please visit 3SBio on the web at http://www.3SBio.com
Investor Contacts Bo Tan Chief Financial Officer 3SBio Inc. Tel: +86-24-2581-1820 Email: ir@3SBio.com Tom Folinsbee Director of Investor Relations 3SBio Inc. Tel: +852-8191-6991 Email: ir@3SBio.com
|SOURCE 3SBio Inc.|
Copyright©2010 PR Newswire.
All rights reserved